BNTC peer analysis
Benitec Biopharma (BNTC) against its competitors: price, today's move, 1-year return and market value side by side.
- BNTC's peers: AUTL (Autolus Therapeutics), GALT (Galectin Therapeutics), LCTX (Lineage Cell Therapeutics), NGNE (Neurogene), OCGN (Ocugen), QSI (Quantum-Si), SLDB (Solid Biosciences).
BNTC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |
| GALT Galectin Therapeutics | $2.81 | -5.70% | -51.05% | $283.46M |
| LCTX Lineage Cell Therapeutics | $0.83 | 0.76% | -51.68% | $208.99M |
| NGNE Neurogene | $22.18 | -3.27% | 5.67% | $459.15M |
| OCGN Ocugen | $0.77 | 5.70% | -32.05% | $262.83M |
| QSI Quantum-Si | $0.93 | -13.09% | -27.35% | $204.34M |
| SLDB Solid Biosciences | $6.25 | -2.95% | 39.51% | $697.57M |
| BNTC Benitec Biopharma | $7.93 | -2.58% | -39.47% | $286.42M |